International Journal of Colorectal Disease

, Volume 27, Issue 6, pp 759–764 | Cite as

A prospective analysis of patient outcome following treatment of T3 rectal cancer with neo-adjuvant chemoradiotherapy and transanal excision

  • Rory P. Kennelly
  • Anna Heeney
  • Anne White
  • David Fennelly
  • Kieran Sheahan
  • John M. P. Hyland
  • P. Ronan O’Connell
  • Desmond C. Winter
Original Article



Local excision is an alternative to anterior or abdomino-perineal resection in patients with early rectal cancer. In more advanced disease, neo-adjuvant therapy (CRXT) can result in significant disease regression such that local excision may be considered. The primary aim was to assess oncological outcome in patients with T3 rectal cancer treated with CRXT and local excision due to unsuitability for or aversion to anterior resection and stoma. The secondary aim was to examine oncological outcomes in patients treated in a similar way in the published literature.


Between July 2006 and July 2009, patients with rectal cancer staged T3, N0/N1, M0 who were deemed unfit for or who refused anterior resection were offered long-course CRXT. Patients were restaged 8 weeks following completion. If there was a good response (regression grade 2 or 3 clinically and radiologically), full thickness transanal excision was performed. All patients were followed regularly (monthly CT abdomen/pelvis and annual endoscopy) to assess for recurrence of disease. A literature search of PubMed was performed to identify all prospective data available of T3 rectal cancers managed with CRXT and local excision.


Ten patients were treated over 3 years. Six patients had complete pathological response, while four patients had a partial response. The resection margins following local excision were clear in all. There was no local recurrence (median follow-up 24 months, range 9–42 months).


Neo-adjuvant chemoradiotherapy and local excision is an option in patients unfit for or averse to major surgical resection if there is a good response to CRXT.


Neo-adjuvant therapy Local excision T3 rectal cancer 


Conflict of interest

The authors state that they have no conflict of interest.


  1. 1.
    Alves A, Panis Y, Pocard M, Regimbeau JM, Valleur P (1999) Management of anastomotic leakage after nondiverted large bowel resection. J Am Coll Surg 189:554–559PubMedCrossRefGoogle Scholar
  2. 2.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K (2008) A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 15:3471–3477PubMedCrossRefGoogle Scholar
  3. 3.
    Bretagnol F, Rullier E, George B, Warren BF, Mortensen NJ (2007) Local therapy for rectal cancer: still controversial? Dis Colon Rectum 50:523–533PubMedCrossRefGoogle Scholar
  4. 4.
    Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Kepka L, Winkler-Spytkowska B, Suwinski R, Oledzki J, Stryczynska G, Wieczorek A, Serkies K, Rogowska D, Tokar P (2005) Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol 76:234–240PubMedCrossRefGoogle Scholar
  5. 5.
    Guillem JG, az-Gonzalez JA, Minsky BD, Valentini V, Jeong SY, Rodriguez-Bigas MA, Coco C, Leon R, Hernandez-Lizoain JL, Aristu JJ, Riedel ER, Nitti D, Wong WD, Pucciarelli S (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 26:368–373PubMedCrossRefGoogle Scholar
  6. 6.
    Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, Paty PB, Weiser MR, Klimstra D, Saltz L, Minsky BD, Wong WD (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829–836PubMedCrossRefGoogle Scholar
  7. 7.
    Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva E, Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717PubMedGoogle Scholar
  8. 8.
    Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, Kiss D, Cecconello I (2008) Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 51:277–283PubMedCrossRefGoogle Scholar
  9. 9.
    Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133:894–899PubMedCrossRefGoogle Scholar
  10. 10.
    Kennelly R, Winter DC (2010) Quality assurance measures in rectal cancer: caveat utilitor. Gut 59:139–140PubMedCrossRefGoogle Scholar
  11. 11.
    Mignanelli ED, de Campos-Lobato LF, Stocchi L, Lavery IC, Dietz DW (2010) Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum 53:251–256PubMedCrossRefGoogle Scholar
  12. 12.
    Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206PubMedCrossRefGoogle Scholar
  13. 13.
    Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ (2004) Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 47:825–831PubMedCrossRefGoogle Scholar
  14. 14.
    Shabbir J, Britton DC (2010) Stoma complications: a literature overview. Colorectal Dis 12:958–964PubMedCrossRefGoogle Scholar
  15. 15.
    Shivnani AT, Small W Jr, Stryker SJ, Kiel KD, Lim S, Halverson AL, Talamonti MS (2007) Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg 193:389–393PubMedCrossRefGoogle Scholar
  16. 16.
    Smith FM, Coffey JC, Khasri NM, Walsh MF, Parfrey N, Gaffney E, Stephens R, Kennedy MJ, Kirwan W, Redmond HP (2005) Sentinel nodes are identifiable in formalin-fixed specimens after surgeon-performed ex vivo sentinel lymph node mapping in colorectal cancer. Ann Surg Oncol 12:504–509PubMedCrossRefGoogle Scholar
  17. 17.
    Smith FM, Waldron D, Winter DC (2010) Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 97:1752–1764PubMedCrossRefGoogle Scholar
  18. 18.
    Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71PubMedCrossRefGoogle Scholar
  19. 19.
    Tsikitis VL, Larson DW, Poola VP, Nelson H, Wolff BG, Pemberton JH, Cima RR (2009) Postoperative morbidity with diversion after low anterior resection in the era of neoadjuvant therapy: a single institution experience. J Am Coll Surg 209:114–118PubMedCrossRefGoogle Scholar
  20. 20.
    Tulchinsky H, Rabau M, Shacham-Shemueli E, Goldman G, Geva R, Inbar M, Klausner JM, Figer A (2006) Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone? Ann Surg Oncol 13:347–352PubMedCrossRefGoogle Scholar
  21. 21.
    Tytherleigh MG, Warren BF, Mortensen NJ (2008) Management of early rectal cancer. Br J Surg 95:409–423PubMedCrossRefGoogle Scholar
  22. 22.
    Wheeler JM, Warren BF, Mortensen NJ, Ekanyaka N, Kulacoglu H, Jones AC, George BD, Kettlewell MG (2002) Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum 45:1051–1056PubMedCrossRefGoogle Scholar
  23. 23.
    Wiig JN, Larsen SG, Dueland S, Giercksky KE (2005) Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 92:70–75PubMedCrossRefGoogle Scholar
  24. 24.
    Zerz A, Muller-Stich BP, Beck J, Linke GR, Tarantino I, Lange J (2006) Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Dis Colon Rectum 49:919–924PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Rory P. Kennelly
    • 1
  • Anna Heeney
    • 1
  • Anne White
    • 1
  • David Fennelly
    • 2
  • Kieran Sheahan
    • 3
  • John M. P. Hyland
    • 1
  • P. Ronan O’Connell
    • 1
  • Desmond C. Winter
    • 1
  1. 1.Department of Surgery, St. Vincent’s University Hospital and School of Medicine and Medical SciencesUniversity College DublinDublin 4Ireland
  2. 2.Department of Oncology, St. Vincent’s University Hospital and School of Medicine and Medical SciencesUniversity College DublinDublin 4Ireland
  3. 3.Department of Pathology, St. Vincent’s University Hospital and School of Medicine and Medical SciencesUniversity College DublinDublin 4Ireland

Personalised recommendations